Ketogenic Therapy Shows Promise for Anorexia
Analysis based on 8 articles · First reported Jun 03, 2026 · Last updated Jun 03, 2026
The positive results of the ketogenic therapy study for Anorexia nervosa>>> could lead to increased investment and research in metabolic psychiatry, potentially boosting pharmaceutical and healthcare companies involved in developing and delivering such treatments. This breakthrough offers new hope for patients and may shift treatment paradigms, impacting the market for mental health services and related medical technologies.
A pilot study led by UC San Diego School of Medicine and published in Tata Communications>>> on June 3, 2026, demonstrated the potential of ketogenic therapy for treating Anorexia nervosa>>>. The study, funded by Baszucki Group>>> and led by Dr. Guido Frank>>>, found that a high-fat, low-carbohydrate, moderate-protein Ketogenic diet>>> was feasible and safe for patients with weight-normalized and mildly underweight Anorexia nervosa>>>. Participants showed significant improvements in eating disorder and depressive symptoms, with 72% of completers reaching the recovered range for eating disorder symptoms and all showing improved depression scores. Co-author Dr. Barbara Scolnick>>> highlighted the personal impact, inspired by her niece's recovery using ketogenic therapy. The findings suggest that targeting neurometabolic dysfunction could offer a new approach to this devastating psychiatric disorder, which has a high mortality rate. An extension study for patients with Anorexia nervosa>>> and bulimia nervosa is currently underway.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard